ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1461

Quantitave Analysis of Cadherin-11 and Beta-Catenin Signaling during Proliferation of Rheumatoid Arthritis-Derived Synovial Fibroblast Cells

Ryosuke Yoshioka, Yasuhiro Kita, Asako Nagahira, Atsushi Manno, Naoyuki Makita, Urara Tomita and Masao Murakawa, Asubio Pharma Co., Ltd., Kobe, Japan

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: cytokines, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

[Background/Purpose ] Cadherin-11 (CDH11) is a cadherin adhesion molecule that anchors b-catenin, and is involved with various functions of synovial fibroblast cells (SFCs) during the development of rheumatoid arthritis (RA). However, the functional mechanism of CDH11 during RA-SFC proliferation is unclear. The aim of our study was to clarify the involvement of CDH11 and b-catenin signaling during human RA-SFC proliferation.

[Methods ] In order to investigate the involvement of CDH11 and b-catenin to proliferation, BrdU incorporation assay with each siRNA treatment was carried out. The effect of knockdown was determined by western blotting and immunohistochemistry. The values of Emax and EC50 in proliferation were caluculated by regression analysis with GraphPad Prism.

[Results ]Using CDH11 specific siRNAs, there were a 42% reduction in IL-1b-induced human RA-SFC proliferation and a 64% reduction in b-catenin protein levels. When b-catenin specific siRNAs were applied, there was a 63% reduction in IL-1b-induced RA-SFC proliferation. The EC50values for IL-1b during RA-SFC proliferation via CDH11-mediated b-catenin-dependent, total b-catenin-dependent, and b-catenin-independent signaling were 0.0015, 0.016, and 0.18 ng/mL, respectively. Blocking homophilic CDH11 ligation with a CDH11 neutralizing antibody did not decrease IL-1b-induced RA-SFC proliferation.

[Conclusion ]  CDH11-mediated b-catenin signaling was 42% involved in IL-1b-induced human RA-SFC proliferation and had the highest susceptibility to IL-1b. The mode of action for CDH11 during the cell proliferation was likely associated with a pool of b-catenin protein. In contrast to IL-1b, CDH11 and b-catenin were not involved in TNF-a-induced RA-SFC proliferation.


Disclosure:

R. Yoshioka,
None;

Y. Kita,
None;

A. Nagahira,
None;

A. Manno,
None;

N. Makita,
None;

U. Tomita,
None;

M. Murakawa,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantitave-analysis-of-cadherin-11-and-beta-catenin-signaling-during-proliferation-of-rheumatoid-arthritis-derived-synovial-fibroblast-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology